糖尿病患者在使用新型磺脲类化合物Ro 6-4563治疗前后的葡萄糖耐量、血浆胰岛素和血脂情况。 - Suppr

Suppr

超能文献

Glucose tolerance, plasma insulin and lipids in diabetic subjects before and after treatment with a new sulfonylurea compounds, Ro 6-4563.

作者信息

Berchtold P, Björntorp P, Gustafson A, Jonsson A, Fagerberg S E

出版信息

Eur J Clin Pharmacol. 1971 Dec;4(1):22-8. doi: 10.1007/BF00568894.

DOI:10.1007/BF00568894

PMID:5151389

Abstract

摘要

相似文献

Glucose tolerance, plasma insulin and lipids in diabetic subjects before and after treatment with a new sulfonylurea compounds, Ro 6-4563.糖尿病患者在使用新型磺脲类化合物Ro 6-4563治疗前后的葡萄糖耐量、血浆胰岛素和血脂情况。

Eur J Clin Pharmacol. 1971 Dec;4(1):22-8. doi: 10.1007/BF00568894.

Clinical evaluation of glibornuride (glutril): a new oral antidiabetic drug.格列本脲（优降糖）的临床评价：一种新型口服抗糖尿病药物。

S Afr Med J. 1973 Sep 15;47(36):1638-42.

[Clinical experiences in long-term therapy of adult diabetes using glibornuride (Ro 6-4563)].[使用格列本脲（Ro 6-4563）对成人糖尿病进行长期治疗的临床经验]

Med Klin. 1973 Mar 23;68(12):376-85.

[Results of a clinical test on the oral antidiabetic agent glibornuride (Ro 6-4563)].[口服抗糖尿病药物格列波脲（Ro 6-4563）的临床试验结果]

Wien Med Wochenschr. 1973 Apr 28;123(17):277-82.

Circadian variations of carbohydrate tolerance in maturity onset diabetics treated with sulfonylureas.

Horm Metab Res. 1974 Sep;6(5):386-91. doi: 10.1055/s-0028-1093830.

Modifications of glycemia and insulinemia in diabetics treated with glipizide (K 4024), a new sulfonylurea.

Arzneimittelforschung. 1972 Nov;22(11):1885-8.

[Blood lipid/variations in the diabetic. I. Preventive note].

Clin Ter. 1976 Feb 15;76(3):261-4.

Serum insulin, glucose, and lipid levels among mild diabetics in relation to incidence of vascular complications.

Lancet. 1971 May 1;1(7705):880-3. doi: 10.1016/s0140-6736(71)92442-1.

[Blood sugar and plasma lipids in fasting diabetics and in metabolically healthy subjects (author's transl)].空腹糖尿病患者和代谢健康受试者的血糖与血脂（作者译）

MMW Munch Med Wochenschr. 1974 Jan 11;116(2):49-52.

[Effects of treatment with glipizide-metformin on the behavior of blood sugar, insulin and lipids after intravenous administration of glucose in diabetic subjects].格列吡嗪-二甲双胍治疗对糖尿病患者静脉注射葡萄糖后血糖、胰岛素及血脂行为的影响

G Clin Med. 1974 Nov;55(11):798-818.

本文引用的文献

THE ORAL HYPOGLYCEMIC COMPOUNDS.口服降糖化合物。

Med Clin North Am. 1965 Jul;49:929-38. doi: 10.1016/s0025-7125(16)33286-2.

A SYSTEM FOR PHENOTYPING HYPERLIPOPROTEINEMIA.一种用于高脂蛋白血症表型分析的系统。

Circulation. 1965 Mar;31:321-7. doi: 10.1161/01.cir.31.3.321.

EFFECT OF ORAL HYPOGLYCEMIC AGENTS ON SERUM INSULIN-LIKE ACTIVITY OF PATIENTS WITH VARIOUS DEGREES OF CARBOHYDRATE INTOLERANCE.口服降糖药对不同程度碳水化合物不耐受患者血清胰岛素样活性的影响。

Metabolism. 1965 Jan;14:26-30. doi: 10.1016/0026-0495(65)90078-8.

EFFECT OF ORAL SULFONYLUREA ON PLASMA TRIGLYCERIDES IN DIABETICS.口服磺脲类药物对糖尿病患者血浆甘油三酯的影响。

Diabetes. 1964 Jan-Feb;13:87-9. doi: 10.2337/diab.13.1.87.

Effects of sulfonylurea compounds on hyperlipemia and hypercholesteremia in patients with minimal impairment of glucose tolerance.磺脲类化合物对糖耐量轻度受损患者高脂血症和高胆固醇血症的影响。

Diabetes. 1962;11(Suppl):69-73.

Immunoassay of insulin with insulin antibody preciptate.用胰岛素抗体沉淀物进行胰岛素免疫测定。

Lancet. 1963 Jan 26;1(7274):200. doi: 10.1016/s0140-6736(63)91215-7.

The normal and diabetic patterns of insulin response to glucose.胰岛素对葡萄糖反应的正常和糖尿病模式。

Lancet. 1962 Nov 10;2(7263):955-8. doi: 10.1016/s0140-6736(62)90726-2.

[Determination of glucose in blood, cerebrospinal fluid and urine with a new glucose oxidase reagent].[用一种新型葡萄糖氧化酶试剂测定血液、脑脊液和尿液中的葡萄糖]

Sven Lakartidn. 1962 Oct 18;59:3016-26.

Sharper separation of lipoprotein species by paper electrophoresis in albumin-containing buffer.在含白蛋白缓冲液中通过纸电泳对脂蛋白种类进行更清晰的分离。

J Lab Clin Med. 1963 Mar;61:518-28.

Determination of glycerides in blood serum.血清中甘油酯的测定

Clin Chim Acta. 1959 Mar;4(2):197-205. doi: 10.1016/0009-8981(59)90130-5.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验